Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

News | Heart Failure

May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...

Home May 23, 2022
Home
News | STEMI

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...

Home May 20, 2022
Home
News | Heart Failure

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

Home May 20, 2022
Home
News | Heart Failure

May 19, 2022 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in ...

Home May 19, 2022
Home
News | Womens Cardiovascular Health

May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...

Home May 18, 2022
Home
News | Stroke

May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in ...

Home May 18, 2022
Home
News | Atrial Fibrillation

May 17, 2022 — Results of a new study reveal Black patients hospitalized with atrial fibrillation (AF) are under ...

Home May 17, 2022
Home
News | Cardiovascular Business

May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...

Home May 16, 2022
Home
News | Heart Failure

May 16, 2022 — The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and Bioinf ...

Home May 16, 2022
Home
News | Pharmaceuticals

May 13, 2022 — Bristol Myers Squibb’s mavacamten will stand rather unchallenged in the hypertrophic cardiomyopathy (HCM) ...

Home May 13, 2022
Home
Subscribe Now